Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Dec 27, 2023; 15(12): 2757-2764
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2757
Table 1 General information of patients with peptic ulcer in the two groups
Indicators
Control group (n = 50)
Research group (n = 58)
χ2/t
P value
Sex (male/female)29/2135/230.0610.805
Age (yr)49.10 ± 8.0848.50 ± 7.21
Perforation site (stomach/duodenum/mixed)22/20/820/27/111.0250.599
History of alcoholism (with/without)16/3420/380.0740.785
History of smoking (yes/no)13/3713/450.1890.664
Table 2 Therapeutic effects in the two groups of patients with peptic ulcer
Indicators
Control group (n = 50)
Research group (n = 58)
χ2
P value
Marked response22 (44.00)30 (51.72)
Response15 (30.00)22 (37.93)
Nonresponse13 (26.00)6 (10.34)
Overall response37 (74.00)52 (89.66)4.5390.033
Table 3 Complications of patients with peptic ulcer in the two groups
Indicators
Control group (n = 50)
Research group (n = 58)
χ2
P value
Perforation0 (0.00)0 (0.00)
Hemorrhage3 (6.00)0 (0.00)
Pyloric obstruction3 (6.00)0 (0.00)
Total6 (12.00)0 (0.00)7.3690.007